Allarity Therapeutics, Inc. (ALLR) Dividend History

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment. The company specializes in identifying targeted therapies based on tumor biology and genetic profiles to improve patient outcomes. Previously known as Oncothyreon Inc., Allarity aims to advance its pipeline through research and partnerships in oncology.

24 School St., 2nd Floor, Boston, MA, 02108
Phone: 401-426-4664
Website: https://www.allarity.com

Dividend History

Allarity Therapeutics, Inc. currently does not pay dividends

Company News

Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization

Allarity Therapeutics signed a non-exclusive licensing agreement with an undisclosed EU-based biotechnology company, providing access to proprietary DRP® algorithms in breast cancer and laboratory services, which validates their drug response prediction technology.

GlobeNewswire Inc.
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Enphase Energy reported mixed Q2 results, leading to a rise in its stock price. Several other companies saw significant pre-market movements, both positive and negative, due to various news and earnings reports.

Benzinga

Featured Companies: ATCH AZTR CJET DRMA ENPH NIVF PMNT RGC SFL SOAR STX TSLA UP VSTM
All You Need to Know About Allarity Therapeutics, Inc. (ALLR) Rating Upgrade to Buy

Allarity Therapeutics, Inc. (ALLR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research

Page data last updated 07/23/2025 04:25:26 UTC